Background Image
Previous Page  38-39 / 54 Next Page
Information
Show Menu
Previous Page 38-39 / 54 Next Page
Page Background

Diretriz

Diretriz

38

39

protocol for a clustered, randomized clinical trial. BMC Fam

Pract 2011;12:23.

80.

Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; Zolong

Study Group. Long-term efficacy and safety of zolpidem

extended-release 12.5 mg, administered 3 to 7 nights per week

for 24 weeks, in patients with chronic primary insomnia:

a 6-month, randomized, double-blind, placebo-controlled,

parallel-group, multicenter study. Sleep 2008;31:79-90.

81.

Siriwardena AN, Qureshi MZ, Dyas JV, Middleton H, Orner

R. Magic bullets for insomnia? Patients’ use and experiences of

newer (Z drugs) versus older (benzodiazepine) hypnotics for

sleep problems in primary care. Br J Gen Pract 2008;58:417-22

82.

Glass J, LanctôtKL,HerrmannN, SprouleBA, BustoUE. Sedative

hypnotics in older people with insomnia: meta-analysis of risks

and benefits. BMJ. 2005;331:1169.

83.

Jana AK, Arora M, Khess CR, Praharaj SK. A case of zolpidem

dependence successfully detoxified with clonazepam. Am J

Addict. 2008;17:343-4.

84.

Oulis P, Nakkas G, Masdrakis VG. Pregabalin in zolpidem

dependence and withdrawal. Clin Neuropharmacol 2011;34:90-

1.

85.

Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian

R. “Cognitive Behavioral Therapy for Treatment of Chronic

Primary Insomnia: A Randomized Controlled Trial” JAMA

2001;285:1856-64.

86.

Matthews EE, Arnedt JT, McCarthy MS, Cuddihy LJ, Aloia

MS. Adherence to cognitive behavioral therapy for insomnia:

A systematic review. Sleep Med Rev 2013. pii: S1087-

0792(13)00004-X.

87.

Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke

B, Brown T, et al. “Practice parameters for the psychological

and behavioral treatment of insomnia: an update. An American

Academy of Sleep Medicine Report”. Sleep 2006;29:1415-9.

88.

Pech M, O’Kearney R. A randomized controlled trial of

problem-solving therapy compared to cognitive therapy for the

treatment of insomnia in adults. Sleep 2013;36:739-49.

89.

Morin CM, Hauri P, Espie CA, Spielman AJ, Buysse DJ, Bootzin

RR. Nonpharmacological treatment of chronic insomnia. Sleep

1999;22:1134-45.

90.

Chesson Jr A, Anderson MD, Littner M, Davila D, Hartse K,

Johnson S, et al. Pratical Parameters for the Nonpharmacological

Treatment of Chonic Insomnia. Sleep 1999;22:1128-33.

91.

Morin CM, Culbert JP, Schwartz SM. “Nonpharmacological

interventions for insomnia: a meta-analysis of treatment

efficacy”. Am J Psychiatry 1994; 151:1172-80.

92. Kirisoglu C, Guilleminault C. Twenty minutes versus forty-five

minutes morning bright light treatment on sleep onset insomnia

in elderly subjects. J Psychosom Res 2004;56:537-42.

93.

Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C,

et al. Cognitive behavioral therapy, singly and combined with

medication, for persistent insomnia: a randomized controlled

trial. JAMA 2009; 20;301:2005-15.

94.

Belleville G, Guay C, Guay B, Morin CM. Hypnotic taper with or

without self-help treatment of insomnia: a randomized clinical

trial. J Consult Clin Psychol 2007;75:325-35.

95.

Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J,

Vallières A. Randomized clinical trial of supervised tapering

and cognitive behavior therapy to facilitate benzodiazepine

discontinuation in older adults with chronic insomnia. Am J

Psychiatry 2004;161:332-42.